Trial Profile

Phase IIa Randomized, Double-blind, and Placebo-controlled Multicenter Split Body Trial of Repeated Doses of ACOU085 for the Prevention of Hearing Loss in Testicular Cancer Patients Receiving Cisplatin

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 16 Jul 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Jun 2026 According to an Acousia Therapeutics media release, Professor Hubert Lowenheim, Chair of Otorhinolaryngology - Head & Neck Surgery at Tubingen University Medical Center is the Scientific Supervisor of the PROHEAR study.
12 Jun 2026 According to an Acousia Therapeutics media release, further analysis of the PROHEAR study results, is ongoing and will be submitted for publication in a peer-reviewed journal.
12 Jun 2026 Status changed to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com